1.Pediatric liver transplantation for metabolic liver disease:report of 42 cases
Liying SUN ; Zhijun ZHU ; Lin WEI ; Yanling YANG ; Wei QU ; Zhigui ZENG ; Ying LIU ; Enhui HE ; Liang ZHANG ; Xiaoying LI ; Jianrui ZHANG ; Feiyi YAN ; Yule TAN ; Jun WANG
Chinese Journal of Organ Transplantation 2017;38(6):337-342
Objective To Analyze the clinical outcomes of pediatric liver transplantation (LT) for liver-based metabolic disorders.Methods We conducted a retrospective analysis on 42 pediatric patients with liver-based metabolic disorders from June 2013 to March 2017,and analyzed the pediatric end stage liver disease model (PELD),growth and development,type of transplant,postoperative complications and prognosis of patients.Results There were 42 children with liver-based metabolic disorders (15.56%) out of all the 270 children who underwent LT.The median age was 51.0 months (range,3.4-160.9 months).Of the 42 children,19 received living donor liver transplantation (LDLT),18 cases received deceased donor liver transplantation (DDLT) and 5 cases received domino liver transplantation.1-,2-and 3-year cumulative survival rate of 42 recipients was 97.7%,93.6% and 93.6%,and that of the grafts was 95.3%,91.4% and 91.4%,respectively.As compared with the 194 children with biliary atresia who underwent LT,significant difference was found in PELD and weight Z-score between the two groups.Conclusion Liver transplantation is a valuable option for children with metabolic disorders,and it has gained a better prognosis.
2.Differential diagnosis for breast ductal carcinoma in situ and plasma cell mastitis by magnetic resonance imaging.
Yu YANG ; Yanfang HUANG ; Ping LI ; Jinhui HU ; Bo JIANG ; Xiangle ZHOU ; Feiyi TAN
Journal of Central South University(Medical Sciences) 2018;43(10):1123-1130
To investigate the magnetic resonance imaging (MRI) features for ductal carcinoma in situ (DCIS) and plasma cell mastitis (PCM) , and to improve diagnostic accuracy for DCIS and PCM.
Methods: The MRI morphology confirmed by surgical pathology and dynamic enhancement for 35 patients with DCIS and 45 patients with PCM were retrospectively analyzed, which included T1 pre-scan high signal, enhanced distribution characteristics, internal strengthening mode, whether centrifugation or centripetal diffusion, dynamic enhancement curve morphology, diffusion-weighted imaging (DWI) signal characteristics, and apparent diffusion coefficient (ADC) values.
Results: The segmental distribution, clustered ring, T1 pre-catheters diffusion and the dynamic delayed concentric diffusion were more common in DCIS than those in PCM (P<0.05). Regional distribution, internal heterogeneity enhancement, and enhanced delay period eccentric diffusion were more common in PCM than those in DCIS (P<0.05). In the PCM group, nipple repertoire, DWI center high signal, adjacent skin thickening, and sinus formation were significantly higher than those in the DCIS group (P<0.05).
Conclusion: Both DCIS and PCM show a non-mass like enhancement on MRI. Images in DCIS mostly show duct-like, branch-like and segment-like distribution. The internal enhancement mode is centripetal diffusion. Images in PCM mostly show regional distribution, and the inside displays heterogeneity enhancement with the adjacent skin thickening and nipple subsided.
Breast Neoplasms
;
diagnostic imaging
;
Carcinoma, Ductal, Breast
;
diagnostic imaging
;
Contrast Media
;
Diagnosis, Differential
;
Female
;
Humans
;
Magnetic Resonance Imaging
;
Mastitis
;
diagnostic imaging
;
Plasma Cells
;
pathology
;
Retrospective Studies